Drugs / Allogeneic Human Umbilical Cord Mesenchymal Stem Cells
Allogeneic Human Umbilical Cord Mesenchymal Stem Cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT04939077 | Nov 2019 → Jul 2022 | left ventricular failure, myocardial ischemia | Shanghai East Hospital | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Allogeneic Human Umbilical Cord Mesenchymal Stem Cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04939077 ↗ |
| Modality | Cell therapy | “cell therapy group” NCT04939077 ↗ |
| Route | Other | “Human Umbilical Cord Mesenchymal Stem Cells were injected at the edge of the myocardial infarction area” NCT04939077 ↗ |